Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

NCT02806791 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Blood Diseases

Interventions

DRUG: FILGRASTIM

Sponsor

Azienda Ospedaliera San Giovanni Battista